Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Autologous fibrin glue is a patient-specific, blood-derived platelet-concentrate preparation investigated by Inonu University for management of palatal donor-site wounds after free gingival graft surgery. The preparation is produced from the patient's own blood and applied to the palatal wound as an adhesive fibrin-rich biologic matrix. It is intended to support hemostasis and tissue repair through the local fibrin scaffold and platelet-derived mediators that may promote fibroblast activity and angiogenesis. In a randomized controlled clinical trial, autologous fibrin glue improved wound-healing and postoperative morbidity measures versus control treatment and showed superior wound-healing measures to injectable platelet-rich fibrin in this setting. ([link.springer.com](https://link.springer.com/article/10.1007/s00784-020-03320-6))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on autologous fibrin glue.